AsttraZeneca Pharmaceuticals LP recalls Airsupra (albuterol and budesonide) inhalation aerosol, 90 mcg/80 mcg per inhalation, packaged in a) 120-inhalation cani
Recalled May 28, 2025 · FDA recall D-0444-2025 · AsttraZeneca Pharmaceuticals
Hazard
Defective delivery system · FDA Class II
Units
a) 807,837 canisters; b) 235,698 canisters
Sold at
USA Nationwide
Description
Defective delivery system
Product
Airsupra (albuterol and budesonide) inhalation aerosol, 90 mcg/80 mcg per inhalation, packaged in a) 120-inhalation canister (NDC 0310-9080-12) b) 28-inhalation canister (NDC 0310-9080-28), Rx only, Manufactured for: AstraZeneca Pharmaceuticals LP, Wilmington, DE 19850, By: AstraZeneca Dunkerque Production (AZDP), Dunkerque, France, Product of France, .
Manufacturer(s)
AsttraZeneca Pharmaceuticals LP
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →